Cervical cancer trials in Spain

In Spain 23 Also abroad 532

23 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Where
A Coruña, Barcelona, Córdoba, Girona, L'Hospitalet de Llobregat, Madrid, Valencia
Age
15 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00
Phase 3Taking people
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Where
Barcelona, Córdoba, Girona, Madrid, Valencia
Age
18 years and over
People
1,023 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07216703 · EU 2025-521514-26-00
Phase 1Taking people
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Where
Barcelona, Madrid, Valencia
Age
18 years and over
People
575 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06400472 · EU 2024-511238-11-00
Phase 1Taking people
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Where
L'Hospitalet de Llobregat, Madrid, Sevilla
Age
18 years and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00
Phase 2Taking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Barcelona, L'Hospitalet de Llobregat, Madrid
Age
18 years and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
A Coruña, Barcelona, Girona, L'Hospitalet de Llobregat, Logrono
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
Phase 1/2Taking people
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Where
Barcelona, Madrid
Age
18 years and over
People
248 worldwide
Run by
Terremoto Biosciences Inc.
See details and how to joinNCT07109726
Phase 2Taking people
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Where
Barcelona, Madrid, Málaga, Seville, Valencia
Age
18 years and over
People
740 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Sevilla
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 3Taking people
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Where
Barcelona, Girona, Madrid
Age
18 years and over
People
510 worldwide
Run by
Institut Claudius Regaud
See details and how to joinNCT05581121
Phase 1Taking people
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Where
Barcelona, Madrid, Piqueras, Seville
Age
18 years and over
People
540 worldwide
Run by
SystImmune Inc.
See details and how to joinNCT05983432
Phase 4Taking people
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer
Where
Barcelona, Madrid, Pamplona, Valencia
Age
18 years and over
People
120
Run by
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
See details and how to join2025-521460-36-00 · EU 2025-521460-36-00
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Badalona, Barcelona, Madrid, Málaga, Pamplona
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 1/2Taking people
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Where
Barcelona, Madrid, Valencia
Age
18 years and over
People
366 worldwide
Run by
Marengo Therapeutics, Inc.
See details and how to joinNCT05592626 · EU 2023-505334-10-01
Phase 2Taking people
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Where
Barcelona
Age
18 years and over
People
24 worldwide
Run by
Vall D Hebron Institute Of Oncology
See details and how to join2023-506400-99-00 · EU 2023-506400-99-00
Phase 1/2Taking people
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Where
Barcelona, Logroño, Madrid, Pozuelo de Alarcón, Reus, Sevilla
Age
18 years and over
People
880 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00
Phase 1Taking people
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Where
Barcelona, Elche, Jerez de la Frontera, Madrid, Málaga, Santander
Age
18 years and over
People
1,006 worldwide
Run by
Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00
No phaseTaking people
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Where
Manresa
Age
18 years and over
People
132 worldwide
Run by
Aesculap AG
See details and how to joinNCT06024109
Phase 2Taking people
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Where
Barcelona, Madrid, Santiago de Compostela, Sevilla, Valencia
Age
18 years and over
People
101 worldwide
Run by
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00
Phase 4Taking people
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Where
L'Hospitalet de Llobregat
Age
18 years and over
People
69
Run by
Miquel Angel Pavon Ribas
See details and how to joinNCT05334706
Phase 4Not yet taking people in Spain
Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer
Where
Teià
Age
18 years and over
People
120
Run by
Fundacion Clinic per a la Recerca Biomédica
See details and how to joinNCT07412873
Phase 2Taking people
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
Where
Barcelona
Age
18 years and over
People
40
Run by
Vall d'Hebron Institute of Oncology
See details and how to joinNCT06630611
Phase 3Taking people
Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
Where
Barcelona, Donostia, Madrid, Murcia, San Sebastián de los Reyes, Santa Cruz de Tenerife, Valencia, Zaragoza
Age
18 years to 85 years
People
514 worldwide
Run by
The Central and Eastern European Gynecologic Oncology Group
See details and how to joinNCT04989647 · EU 2023-504973-19-01